Data Snapshot - Tolvaptan

The HSE Medicines Management Programme provide insights into prescribing trends and utilisation for medicines and non-drug products available through the HSE. This Data Snapshot provides an update on utilisation of tolvaptan reimbursed for the treatment of autosomal dominant polycystic kidney disease subject to a managed access protocol.